RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived
Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became widely available.
A new report from the Centers for Disease Control and Prevention shows there was a substantial drop in hospitalizations for respiratory syncytial virus this winter among very young children, who are at the highest risk of becoming severely ill if they contract RSV.
This past winter was the first during which new options for protecting babies from the virus became widely available in the United States, though the products were first introduced in a limited way in advance of the 2023-2024 season.
